Financial Sense Advisors, Inc. Abb Vie Inc. Transaction History

Financial Sense Advisors, Inc.

$294 Million
Q1 2024

A detailed history of Financial Sense Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 12,525 shares of ABBV stock, worth $2.08 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

12,525

Previous 13,390 6.46%

Holding current value

$2.08 Million

Previous $2.08 Million 9.88%

% of portfolio

0.77%

Previous 0.81%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $138,244 - $157,516	-865 Reduced 6.46%	12,525 $2.28 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $105,126 - $118,397	764 Added 6.05%	13,390 $2.08 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $516,859 - $598,340	-3,869 Reduced 23.46%	12,626 $1.88 Million
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $173,720 - $216,183	1,311 Added 8.63%	16,495 $2.22 Million
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $29,789 - $34,307	206 Added 1.38%	15,184 $2.42 Million

Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $346,051 - $415,006	2,502 Added 20.05%	14,978 $2.42 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $5,368 - $6,157	-40 Reduced 0.32%	12,476 $1.67 Million
Q2 2022 Jul 18, 2022	BUY	$137.62 - $174.96 $1.52 Million - $1.94 Million	11,077 Added 769.77%	12,516 $1.92 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $1.49 Million - $1.85 Million	-11,317 Reduced 88.72%	1,439 $233,000
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $4,619 - $5,844	-43 Reduced 0.34%	12,756 $1.73 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $281,960 - $320,067	2,650 Added 26.11%	12,799 $1.38 Million
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $49,343 - $54,971	-469 Reduced 4.42%	10,149 $1.14 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $9,616 - $10,586	94 Added 0.89%	10,618 $1.15 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $48,213 - $65,093	-599 Reduced 5.39%	10,524 $1.13 Million
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $62,112 - $72,900	-723 Reduced 6.1%	11,123 $974,000
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $171,025 - $228,857	-2,331 Reduced 16.44%	11,846 $1.16 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $914,416 - $1.39 Million	14,177 New	14,177 $1.08 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $248,771 - $299,094	-3,950 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $92,965 - $118,831	1,415 Added 55.82%	3,950 $287,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $195,549 - $230,152	2,535 New	2,535 $204,000

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.

Account

Financial Sense Advisors, Inc. Abb Vie Inc. Transaction History